June 09, 2021
Back Page
41
6
Pandemic-reinforced principles of successful drug launch.
June 09, 2021
Features
41
6
In today’s fragmented commercial environment, navigating a more complex set of challenges while adapting new approaches to product launch is critical for biopharma brand teams.
June 09, 2021
Features
41
6
How Gilead readied remdesivir for the COVID challenge.
June 09, 2021
Features
41
6
Inside Regeneron’s monoclonal antibody development to treat COVID.
June 09, 2021
Features
41
6
Past lessons, strong resolve, and complex coordination propel J&J’s vaccine efforts.
June 09, 2021
Features
41
6
Thrust into a commercial-stage company in just months, Moderna moves full steam ahead.
June 09, 2021
Features
41
6
College roommates, industry partnerships help bring Pfizer vaccine to fruition.
June 09, 2021
Features
41
6
Pharm Exec’s latest listing of the top global biopharma sales producers captures the critical business and public health balancing act that was required in the Year of COVID—reinforcing the staying power of building brand value while championing medical innovation.
June 09, 2021
Finance
41
6
What are the reasons behind the slump and what does the future hold?
June 09, 2021
Executive Profile
41
6
Building on a lifelong passion for biomedical research, and then its application in policy and health equity as a leader in various interconnected settings, Michelle McMurry-Heath, president and CEO of BIO, is uniquely positioned as a “translator” for science and social advocacy—and speaking stakeholders to action.
June 09, 2021
Managed Markets
41
6
A business framework for pricing and broader brand strategy.
June 09, 2021
Technology
41
6
How the UK is making progress in this hi-tech field.
June 09, 2021
Leadership
41
6
Leading in a post-quarantine world requires compassion and connection amid employees’ shifting situations.
June 09, 2021
Global Report
41
6
Pandemic triggers urgency around supply chain initiatives.
June 09, 2021
Washington Report
41
6
Separate pushes for vaccine equity, legislation to lower drug costs.
June 09, 2021
From the Editor
41
6
Combined powers of synbio and biopharma point to bright future for industry.
June 09, 2021
Chairman’s Letter
41
6
A letter on the June 2021 issue of Pharm Exec from Chairman and Founder of MJH Life Sciences, Mike Hennessy Sr.
June 09, 2021
Issue PDF
41
6
Click the title above for a link to open the Pharmaceutical Executive June 2021 issue in an interactive PDF format.